Abstract-Cardiac beating arises from the spontaneous rhythmic excitation of sinoatrial (SA) node cells. Here we report that SA node pacemaker activity is critically dependent on Ca 2ϩ /calmodulin-dependent protein kinase II (CaMKII). In freshly dissociated rabbit single SA node cells, inhibition of CaMKII by a specific peptide inhibitor, autocamtide-2 inhibitory peptide (AIP, 10 mol/L), or by KN-93 (0.1 to 3.0 mol/L), but not its inactive analog, KN-92, depressed the rate and amplitude of spontaneous action potentials (APs) in a dose-dependent manner. Strikingly, 10 mol/L AIP and 3 mol/L KN-93 completely arrested SA node cells, which indicates that basal CaMKII activation is obligatory to the genesis of pacemaker AP. To understand the ionic mechanisms of the CaMKII effects, we measured L-type Ca 2ϩ current (I Ca, L ), which contributes both to AP upstroke and to pacemaker depolarization. (1 mol/L), but not its inactive analog, KN-92, decreased I Ca, L amplitude from 12Ϯ2 to 6Ϯ1 pA/pF without altering the shape of the current-voltage relationship. Both AIP and KN-93 shifted the midpoint of the steady-state inactivation curve leftward and markedly slowed the recovery of I Ca, L from inactivation. Similar results were observed using the fast Ca 2ϩ chelator BAPTA, whereas the slow Ca 2ϩ chelator EGTA had no significant effect, which suggests that CaMKII activity is preferentially regulated by local Ca 2ϩ transients. Indeed, confocal immunocytochemical imaging showed that active CaMKII is highly localized beneath the surface membrane in the vicinity of L-type channels and that AIP and KN-93 significantly reduced CaMKII activity. Thus, we conclude that CaMKII plays a vital role in regulating cardiac pacemaker activity mainly via modulating I Ca, L inactivation and reactivation, and local Ca 2ϩ is critically involved in these processes. 
current (I Ca, L ), which contributes both to AP upstroke and to pacemaker depolarization. (1 mol/L), but not its inactive analog, KN-92, decreased I Ca, L amplitude from 12Ϯ2 to 6Ϯ1 pA/pF without altering the shape of the current-voltage relationship. Both AIP and KN-93 shifted the midpoint of the steady-state inactivation curve leftward and markedly slowed the recovery of I Ca, L from inactivation. Similar results were observed using the fast Ca 2ϩ chelator BAPTA, whereas the slow Ca 2ϩ chelator EGTA had no significant effect, which suggests that CaMKII activity is preferentially regulated by local Ca 2ϩ transients. Indeed, confocal immunocytochemical imaging showed that active CaMKII is highly localized beneath the surface membrane in the vicinity of L-type channels and that AIP and KN-93 significantly reduced CaMKII activity. Thus, we conclude that CaMKII plays a vital role in regulating cardiac pacemaker activity mainly via modulating I Ca, L inactivation and reactivation, and local Ca 2ϩ is critically involved in these processes. T he human heart faithfully supplies blood to the body by beating more than 3 billion times in a lifetime. The sinoatrial (SA) node possesses automaticity and serves as the primary physiological pacemaker of the heart. The pacemaker action potential (AP) is initiated in a small group of primary pacemaker cells located in the center of the SA node and then propagates through transitional, peripheral regions to the atrial tissue. 1,2 A number of ionic currents are involved in the SA node pacemaker activity, including 2 delayed rectifier potassium currents (mainly the rapidly activated component, I Kr ), L-and T-type Ca 2ϩ currents (I Ca, L and I Ca, T ), hyperpolarizationactivated cation current (I f ), and others. 3, 4 In primary SA node cells, I Ca, L plays an obligatory role in the generation of rhythmic spontaneous APs, because I Ca, L is an important source of inward current for the AP upstroke 4 and diastolic depolarization. 5, 6 Ca 2ϩ /calmodulin-dependent protein kinase II (CaMKII), a ubiquitous and multifunctional enzyme, is widely involved in Ca 2ϩ -dependent cellular processes. Signals that increase [Ca 2ϩ ] i activate CaMKII. 7 This kinase also retrospectively targets an array of molecules that affect Ca 2ϩ levels. In the heart, CaMKII regulates the sarcoplasmic reticulum (SR) Ca 2ϩ cycling by phosphorylating the Ca 2ϩ release channels and the SR Ca 2ϩ -ATPase regulator, phospholamban. 8, 9 In ventricular myocytes, activated CaMKII localizes closely to cardiac sarcolemmal membranes and mediates a frequencyand Ca 2ϩ -dependent facilitation of I Ca, L , which counteracts the voltage-and Ca 2ϩ -dependent inactivation of the channel. 10 -12 Furthermore, autophosphorylated (active) CaMKII retains its catalytic activity even in the absence of an increase in [Ca 2ϩ ] i 13-15 ; this biochemical property enables CaMKII to prolong the action of a transient Ca 2ϩ signal or to function as a "frequency detector" of repetitive Ca 2ϩ signals, which makes it ideally suited for the regulation of rhythmic activities such as heart beats.
Given the important role of I Ca, L in initiating SA node pacemaker activity and the role of CaMKII in modulating I Ca, L , we hypothesize that CaMKII may be critically involved in the regulation of SA node spontaneous excitations. Here we examined the effects of CaMKII on SA node spontaneous excitation and underlying ionic mechanisms, particularly modulation of I Ca, L . The present results demonstrate that inhibition of CaMKII with a specific peptide inhibitor or a synthetic inhibitor, KN-93, can completely arrest SA node cells largely as a result of depressed I Ca, L amplitude, reduced window current, and slowed recovery of L-type Ca 2ϩ channels from inactivation. This finding shows, for the first time, a pivotal role of CaMKII in regulating cardiac pacemaker activity.
Materials and Methods

SA Node Cell Isolation
Single SA node cells were isolated according to the modified method of Ito and Ono. 16 Albino rabbits weighing 1.8 to 2.2 kg were deeply anesthetized with sodium pentobarbital (50 to 90 mg/kg). The heart was rapidly excised, and the SA node region was excised and cut into small strips (0.5 to 1.0 mm wide) perpendicular to the crista terminalis. The strips were first incubated in Ca 2ϩ -free Tyrode solution containing (in mmol/L) NaCl 140, KCl 5.4, MgCl 2 0.5, NaH 2 PO 4 0.33, HEPES 5, and glucose 5.5 (pH 6.9) at 33°C and then in the Ca 2ϩ -free Tyrode solution containing elastase type IIA (0.6 mg/mL; Sigma), collagenase B (0.6 mg/mL; Boehringer Mannheim), and 0.1% BSA for 30 minutes at 33°C. Thereafter, the strips were washed and dispersed in a modified Kraftbruhe solution by gentle pipetting and were stored at 4°C.
Electrophysiological Recordings
Perforated-or ruptured-patch-clamp techniques were used to record spontaneous APs or I Ca, L , respectively, with Axopatch-1D patchclamp amplifier (Axon Instruments). The bath temperature was maintained at 34Ϯ0.5°C. For perforated-patch experiments, amphotericin B (400 g/mL, Sigma) or ␤-escin (40 to 50 mol/L, 17 Sigma) was added to the pipette solution. All potentials were corrected by subtracting the pipette-to-bath liquid junction potential, which was 13 mV for the perforated patch recordings of APs, as calculated using the Clampex 7 software package (Axon Instruments).
For I Ca, L recordings, depolarizing voltage-clamp pulses (300 ms) were applied from a holding potential of Ϫ50 mV; 10 to 30 mol/L tetrodotoxin and 4 mmol/L 4-aminopyridine were added to block interfering currents. Activation-voltage relationships of I Ca, L were estimated from normalized conductance-voltage curves. 11, 18 Steadystate inactivation-voltage relationships of I Ca, L were measured using a 2-pulse protocol in which a variable-amplitude prepulse of 2000 ms was followed by a 200-ms test pulse to 0 mV from a holding potential of Ϫ70 mV. To measure the time required for recovery of Ca 2ϩ channels from voltage-dependent inactivation, the cell was depolarized to 0 mV for 300 ms to inactivate Ca 2ϩ channels, then repolarized to Ϫ50 mV for various durations to allow channel recovery (20 to 2300 ms), and finally depolarized to 0 mV for 300 ms. The percentage of I Ca, L restored in the test pulse was used to calculate the channel recovery.
Immunocytochemical Staining of CaMKII
The intracellular distribution of total and autophosphorylated (active) CaMKII was visualized in isolated SA node cells by confocal fluorescence microscopy. 10 Cells were incubated overnight at 4°C with the monoclonal CaMKII antibodies (Affinity Bioreagents Inc), followed by an incubation for 4 hours with a Texas Red-conjugated anti-mouse antibody (Vector Laboratories Inc). Immunostaining of an autophosphorylated form of CaMKII was repeated after 30-minute pretreatment of cells with either of the CaMKII inhibitors KN-93 or autocamtide-2 inhibitory peptide (AIP). Immunostaining was then detected with a laser scanning confocal microscope (LSM-410, Zeiss).
Statistical Analysis
Data are given as meanϮSEM. The difference of mean values were analyzed by Student t test; ANOVA was used to compare groups of data, and PϽ0.05 was considered statistically significant.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
Results
Inhibition of CaMKII Suppresses Spontaneous AP in SA Node Cells
We studied spontaneous excitation of freshly isolated, spindle-shaped SA node cells using the perforated patchclamp technique (Figure 1 ). Under control conditions at 34°C, parameters of AP were as follows: amplitude, 84.2Ϯ2.9 mV; duration at 50% repolarization, 102.2Ϯ5.7 ms; upstroke velocity (dV/dt), 8.5Ϯ1.0 V/s; and cycle length, 357.1Ϯ17.0 ms (nϭ24). The diastolic depolarization rate was 57.6Ϯ3.8 mV/s, and the maximum diastolic potential (MDP) was Ϫ65.5Ϯ1.4 mV (nϭ24). These values are highly comparable with those reported previously. 4 Figure 1 shows effects of a highly specific peptide inhibitor of CaMKII (AIP, membrane-permeable form, 10 mol/L) on SA node pacemaking. This peptide, which corresponds to an "autoinhibitory" domain of CaMKII, 19 decreased AP amplitude and absolute value of MDP, reduced the rate of spontaneous excitations of the SA node cells, and in 3 out of 4 experiments completely arrested SA node cells ( Figure 1 ). These effects were achieved within 20 to 30 minutes and were largely reversible on washout ( Figure 1A ). Further evidence that SA node pacemaking depends on CaMKII was obtained by superfusing cells with a specific CaMKII inhibitor, KN-93. 20 Figures 2A through 2C show representative continuous recordings of APs in the absence (left panels) and presence (right panels) of KN-93, at different concentrations. KN-93 at a low concentration (0.3 mol/L) reduced the rate of spontaneous excitations (PϽ0.05) and absolute value of MDP ( Figure 2A) ; these effects were reversible on washout of the inhibitor (data not shown). In the presence of 1 mol/L KN-93, the negative chronotropic effect was more pronounced; excitations became irregular, and AP amplitudes became unstable. The disturbed pacemaker activity was associated with a Ϸ10-mV reduction of MDP ( Figure 2B ). More strikingly, application of a higher concentration of KN-93 (3 mol/L) completely abolished spontaneous excitations ( Figure 2C ). In contrast, KN-92 (1 mol/L, nϭ6), an inactive KN-93 analogue, had no significant effect on any examined AP parameter ( Figure 2D ), confirming the specificity of the CaMKII inhibitor. Figures 3A through 3D summarize the average effects of KN-93 on AP parameters that were similar to those induced by AIP ( Figure 1B ). The CaMKII inhibitor induced a robust change in all AP parameters in a dose-dependent manner. Spontaneous excitations were abolished in 2 of 6 cells and in 4 of 4 cells by KN-93 at concentrations of 1 and 3 mol/L, respectively. Taken together, our data indicate that CaMKII plays an essential role in SA node pacemaking and that basal CaMKII activation is indispensable for the SA node cell to generate APs.
Effects of CaMKII on I Ca, L
To delineate the ionic mechanisms underlying CaMKIImediated modulation of SA node pacemaker activity, we measured I Ca, L in the presence or absence of the CaMKII inhibitors, using a whole-cell patch-clamp configuration. KN-93 (1 mol/L) induced a 50% decrease in I Ca, L amplitude (from 12Ϯ2 to 6Ϯ1 pA/pF at 0 mV, PϽ0.01) without altering the current-voltage relationship ( Figure 4A ). The timedependent inactivation of I Ca, L fitted by a double-exponential function was not significantly altered by KN-93 ( f ϭ6.9Ϯ0.27 ms and s ϭ37.6Ϯ1.4 ms [nϭ19] in control To define the specific mode of CaMKII-mediated modulation of I Ca, L , we examined the voltage-dependent activation and steady-state inactivation of I Ca, L . As shown in Figure 4B , the threshold for I Ca, L activation was ϷϪ40 mV, and the saturation occurred at Ϸϩ10 mV in the SA node cells. Inhibition of CaMKII (KN-93, 1 mol/L) had virtually no effect on the slope factor (7.3Ϯ0.2 mV in controls versus 7.4Ϯ0.4 mV with KN-93), the midpoint voltage (V h ϭϪ16.1Ϯ1.3 mV in control versus Ϫ16.1Ϯ1.5 mV with KN-93), or the overall shape of the activation curve. In contrast, inhibition of CaMKII had a profound effect on the steady-state inactivation of the channel, as manifested by a parallel shift of the inactivation curve by 11.2Ϯ1.1 mV (PϽ0.01) toward more negative potentials ( Figure 4B ). In the presence of KN-93, the midpoint inactivation voltage was Ϫ45.2Ϯ1.3 mV, and the slope factor for inactivation was 6.1Ϯ0.2 mV, which indicates that a substantial number of L-type channels must be inactivated at the MDPs (Ϫ54.4Ϯ3.2 mV, nϭ4) in the presence of CaMKII inhibitor ( Figure 4B ). Similarly, AIP (100 mol/L in the pipette solution, Ͼ30 minutes) shifted the steady-state inactivation curve of I Ca, L leftward by 5.3Ϯ0.3 mV (PϽ0.01) without altering the activation curve ( Figure 5A ). Thus, CaMKII activity is required to alleviate the steady-state inactivation of L-type Ca 2ϩ channels, maintaining the channel availability in the pacemaker cells.
In cells undergoing rhythmical excitations, L-type channel recovery from inactivation is another important determinant of channel availability. To gain further insight into the CaMKII-mediated modulation of pacemaker activity, we measured the time course for recovery of I Ca, L from inactivation using a dual-pulse protocol (see Materials and Methods). The results are summarized in Figure 5B . At a holding potential of Ϫ50 mV, the recovery of I Ca, L was fitted by 2 exponentials, with a fast component being predominant ( 1 ϭ71 ms, A 1 ϭ70%; 2 ϭ612 ms, A 2 ϭ30%) . The role of CaMKII in L-type channel reactivation was confirmed by the fact that AIP markedly slowed the recovery of Ca 2ϩ channels from inactivation ( 1 ϭ174 ms, A 1 ϭ50%; 2 ϭ1085 ms, A 2 ϭ50%) ( Figure 5B ). In the presence of KN-93 (1 mol/L, nϭ6), both time constants were also markedly prolonged ( 1 ϭ120 ms; 2 ϭ2000 ms), with the slow component being dominant (A 1 ϭ26%; A 2 ϭ74%). KN-92 (1 mol/L, nϭ6), the inactive analogue of KN-93, had no significant effect on the recovery kinetics of the channel. These results reveal another mode of CaMKII action, ie, ensuring the reactivation of L-type channels during each excitation cycle. The markedly slowed recovery of the channel from inactivation contributes, at least in part, to KN-93-induced reduction of I Ca, L amplitude depicted in Figure 4A . The effects of AIP and KN-93 on I Ca, L indicate that some basal CaMKII activity exists in SA node cells dialyzed with 10 mmol/L EGTA, as is the case in rat ventricular myocytes. 10 The results described above suggest that the inhibitory effects of CaMKII inhibitors on SA node pacemaker activity are largely mediated by suppressing I Ca, L activation and reactivation. Next, we directly tested this idea using an L-type Ca 2ϩ channel blocker, nifedipine (nϭ4). A representative example is shown in Figure 6 . Similar to the CaMKII inhibitor, nifedipine (0.2 mol/L) depressed all of the parameters of AP, including AP frequency, amplitude, rate of AP upstroke, and reduced MDP ( Figure 6B) . After a 5-minute perfusion, nifedipine completely arrested the pacemaker cell ( Figure 6C) . Thus, the effects of CaMKII inhibition on the pacemaker activity can be largely mimicked by a selective blockade of I Ca, L .
Intracellular Localization of CaMKII
To determine intracellular distribution of autophosphorylated (active) as well as total CaMKII in the SA node cell, we used a site-specific antibody against CaMKII phosphorylated at Thr286 and another antibody that recognizes CaMKII regardless of its phosphorylation state. Confocal immunofluorescence imaging showed that active CaMKII was concentrated beneath the surface membrane ( Figure 7B ), whereas total CaMKII was present uniformly in the SA node cell ( Figure  7A ). Figure 7C shows the negative control image obtained in the absence of any primary antibody; the nonspecific staining was negligible. The restricted localization of active CaMKII to the surface membrane is consistent with the idea that CaMKII targets sarcolemmal membrane-delimited substrates, particularly L-type Ca 2ϩ channels, and that CaMKII activity is likely regulated by local Ca 2ϩ gradients in the submembrane microdomains (see below). Pretreatment of cells with agents blocking CaMKII activity, KN-93 or AIP, significantly decreased the amount of the active form of CaMKII ( Figure 7D) , which substantiates the idea that both agents acted through inhibition of CaMKII.
Role of Local Ca 2؉ in CaMKII-Mediated Modulation of Pacemaker Activity
Theoretically, Ca 2ϩ influx through L-type channels as well as I Ca, L -triggered Ca 2ϩ release from the abutting SR may generate a local increase in [Ca 2ϩ ], the activator of CaMKII. We therefore hypothesized that CaMKII is preferentially activated by local high Ca 2ϩ transients in the microdomain of the surface membrane and that the active CaMKII, in turn, However, only BAPTA significantly reduced the rate and amplitude of spontaneous AP by 54% and 14%, respectively, and reduced MDP by 8 mV (Figures 8B through 8D ). It is noteworthy that BAPTA also led to an irregular beating pattern that was characterized by missing beats ( Figure 8A ). In contrast, the slow Ca 2ϩ buffer, EGTA, only slightly reduced the rate of spontaneous excitations and did not change the amplitude of AP as well as MDP (Figure 8 ). In voltage-clamped cells, BAPTA hampered the I Ca, L recovery from inactivation in a manner similar to that of the CaMKII inhibitor KN-93. Specifically, when EGTA (10 mmol/L) in the pipette solution was substituted by BAPTA (10 mmol/L), the I Ca, L recovery time constants were increased to 1 ϭ120 and 2 ϭ3660 ms, respectively. Taken together, these results indicate that in SA node cells, the spontaneous AP and I Ca, L are far more sensitive to BAPTA than to EGTA, which supports the idea that local Ca 2ϩ transients are critically involved in CaMKII-dependent pacemaker activity.
Discussion CaMKII Activation Is Essential to Cardiac Pacemaker Activity
The spontaneous excitation of SA node pacemaker cells in the mammalian heart is under tight neuronal and hormonal control. For instance, ␤-adrenergic stimulation by the adrenal hormone epinephrine or the sympathetic neurotransmitter norepinephrine elicits a positive chronotropic effect through a cAMP/protein kinase A (PKA) signaling pathway. 4, 22 Conversely, parasympathetic stimulation exerts a potent negative chronotropic effect. 23 In the present study, we demonstrated that in SA node cells basal CaMKII activation is essential for pacemaker activity. This conclusion is based on the following lines of evidence: (1) SA node cell pacemaker activity is depressed by the CaMKII inhibitor in a dose-dependent manner ( Figures 1 through 3) ; (2) the abolition of spontaneous excitations by a high concentration of KN-93 (3 mol/L) or inhibitory peptide AIP (10 mol/L) suggests that a minimal level of CaMKII activation is obligatory to the genesis of the spontaneous excitations; and (3) an intermediate inhibition of CaMKII by KN-93 (0.3 to 1 mol/L) or BAPTA (5 mol/L) disrupts the rhythm and stability of pacemaker APs, which indicates that a certain amount of CaMKII activation is required to ensure optimal pacemaker function.
Compared with the well-characterized nervous and hormonal regulation, the CaMKII-mediated regulation of pacemaker activity is unique in several important aspects. First, CaMKII-dependent modulation is intrinsic to the SA node cells, operating tonically to maintain the excitability of the pacemaker cells. Second, in addition to its strong modulatory effects, CaMKII also plays an important permissive role in cardiac pacemaking, as demonstrated in the present study. In this regard, the effect of PKA is mostly modulatory because inhibition of basal PKA activity by 2 mol/L H-89, 24 which fully prevents the positive chronotropic effect induced by the ␤-adrenergic agonist isoproterenol, fails to abolish SA node pacemaker activity (data not shown). Third, CaMKII regulation of the pacemaker activity is a positive feedback by nature because CaMKII, which augments I Ca, L , is activated by local Ca 2ϩ transients produced directly by I Ca, L or indirectly by I Ca, L-induced Ca 2ϩ release from the SR. Finally, the CaMKIImediated modulation could be self-adaptive. For example, an increase in heart rate would, on one hand, reduce the pacemaker I Ca, L because of enhanced voltage-dependent inactivation and insufficient time for the channel recovery from inactivation. On the other hand, on the basis of its "memory" properties, CaMKII would serve as the "frequency detector" to integrate the local Ca 2ϩ signals; the faster the heart beats, the more frequent the local Ca 2ϩ transients, and thus the greater the CaMKII activity. The enhanced CaMKII activity alleviates steady-state inactivation and promotes channel recovery from inactivation, maintaining pacemaker activity at a higher set point. Thus, although negative feedback regulation, eg, I Ca, L inactivation, stabilizes an established pacemaker frequency, the self-adaptive CaMKII activity permits the heart rate to change over a wider dynamic range.
Ionic Mechanism of CaMKII Action
The most prominent effects of CaMKII inhibition were the decrease of AP parameters (frequency, amplitude, and upstroke rate) or even an abolition of the spontaneous excitations (Figures 1 through 3) . A decrease of MDP after CaMKII inhibition per se could not explain the changes in AP parameters, because in control cells membrane depolarization (Ϸ mV) induced an increase rather than a decrease in the rate of spontaneous excitations (data not shown). In KN-93-treated cells, AP parameters were only partially restored when MDP was restored by injection of a hyperpolarizing current (data not shown). To unravel the ionic mechanism underlying the modulatory effects of CaMKII on SA node pacemaker activity, we examined the possible involvement of I Ca, L and found that suppression of CaMKII activity by KN-93 reduces I Ca, L amplitude by 50% ( Figure 4A ), which is similar to previous observations in ventricular myocytes. 25, 26 The recovery of I Ca, L from inactivation is also markedly slowed by AIP ( Figure 5B ), KN-93, or the fast Ca 2ϩ buffer BAPTA. This is consistent with the leftward shift of the steady-state inactivation curve caused by the CaMKII inhibitors, which contributes to the decrease in L-type channel availability, particularly at the depolarized MDP.
In SA node cells, the leftward shift of steady-state inactivation curve of I Ca, L is not associated with any shift of the voltage-dependent activation of the current, resulting in a markedly reduced "window" current (the overlap area of the steady-state inactivation and activation curves; Figures 4B and 5A). It has been shown that in rabbit SA node cells, the L-type window current contributes to the pacemaker potential. 27 Thus, the decrease in the window current could, in part, explain the inhibitory effects of the CaMKII inhibitors on spontaneous excitations of SA node cells.
Because I Ca, L constitutes one of the main ionic currents responsible for excitations of SA node cells, the suppression of I Ca, L provides a straightforward explanation for inhibitory effects of the CaMKII inhibitor on AP. However, the paradox is that a reduction of the inward current was accompanied by a depolarization, instead of a hyperpolarization, of the membrane potential. One possible explanation is that the depression or abolition of AP may secondarily reduce or preclude K ϩ conductance activated by an AP (eg, delayed rectifier K ϩ current 4, 16 ) such that the net result is a reduction in the outward currents and thereby membrane depolarization. This interpretation is supported by a computer simulation of the SA node pacemaker using the OXSOFT HEART model. 28 Direct evidence is given in Figure 6 , which shows that the L-type channel antagonist nifedipine similarly reduces MDP, consistent with the previous reports. 4, 29 Taking these data together, we conclude that modulation of the voltage-and time-dependent properties of L-type channel inactivation by CaMKII is the primary mechanism underlying the CaMKIImediated regulation of SA node pacemaker activity. In addition to I Ca, L , several other ionic currents are involved in SA node pacemaker activity, including I Kr , I f , sustained current, T-type Ca 2ϩ current, and the muscarinic K ϩ current (I KACh ). However, inhibition of I f causes only minor changes in AP parameters. 30 Recent studies in rabbit ventricular myocytes have demonstrated that CaMKII inhibition by peptide AC3-I has no significant effect on I Kr , 26 which suggests that I Kr and I f are not critically involved in CaMKIIdependent regulation of spontaneous excitations. Further studies are required to determine possible contributions of the other pacemaker currents to CaMKII-dependent regulation of SA node pacemaker activity.
Regulation of CaMKII Activation by Local Ca
2؉
Signaling
CaMKII activity is regulated in a Ca 2ϩ -and calmodulindependent manner. To delineate the contribution of local versus global Ca 2ϩ transients in the temporal and spatial control of CaMKII activation, we directly visualized the intracellular distribution of the active versus the total CaMKII and found a uniform distribution of the total CaMKII but a highly localized distribution of the active CaMKII to the subsarcolemmal microdomain. This spatial pattern of active CaMKII in SA node cells fits nicely with the identified functional role of CaMKII in regulating the sarcolemmal Ca 2ϩ channels and supports the idea of a local control of CaMKII activation by local Ca 2ϩ transients. Indeed, a fast Ca 2ϩ buffer, BAPTA, significantly suppressed the spontaneous excitations of SA node cells and slowed I Ca, L recovery from inactivation, which mimics the effects of direct inhibition of CaMKII. In contrast, the slow Ca 2ϩ buffer EGTA has no significant effect on either AP or I Ca, L in these SA node cells, probably because it cannot effectively buffer the local Ca 2ϩ . 21 These results are in agreement with our previous observation in rat ventricular myocytes that BAPTA, but not EGTA, abolishes CaMKIIdependent I Ca, L facilitation during repetitive depolarizations. 10 Thus, subsarcolemmal Ca 2ϩ transients play a critical role in the local activation of CaMKII, which, in turn, mediates a positive feedback regulation of I Ca, L in SA node cells.
In summary, whereas previous studies focused on the role of ␤-adrenergic and muscarinic stimulation in modulation of the heart rate, the present study demonstrates that SA node pacemaker activity is subject to an intrinsic regulation by CaMKII. The CaMKII-mediated regulation is unique as compared with the well-established hormonal or neuronal control because of its inherent positive feedback and selfadaptive properties. In addition, CaMKII may afford an important integrating mechanism for distinct Ca 2ϩ 31 and other signals 32 to regulate heart rate. For example, ␤-adrenergic receptor stimulation may cross-talk with the CaMKII signaling pathway by enhancing I Ca, L and SR Ca 2ϩ cycling or by PKAmediated, Ca 2ϩ -independent phosphorylation of CaMKII at Thr286. 33 Thus, in SA node cells under physiological conditions, CaMKII plays both permissive and modulatory roles in cardiac pacemaker activity via modulating L-type Ca 2ϩ channels.
